UBS Group Portfolio holdings
UBS Group is the Swiss bank holding company behind UBS, which was created in 1998 when Union Bank of Switzerland merged with Swiss Bank Corporation; the holding company was listed in New York in 2014. Its business spans wealth management, investment banking, asset management and banking for individuals and companies. Its asset management arm offers stock, bond, currency, hedge fund, real estate, infrastructure and private equity strategies, which can also be combined in multi-asset portfolios. The group's roots go back to the Bank in Winterthur, founded in 1862, and to Swiss Bank Corporation, started by six private bankers in Basel by 1854. The wealth management arm serves high net worth individuals worldwide, and its US business grew out of Paine Webber, the American brokerage UBS merged with in 2000 and renamed UBS Wealth Management USA in 2003. In 2023 UBS took over Credit Suisse in a rescue deal arranged by the Swiss government and central bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.15B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$611M |
| 3 |
SpaceX
SPCX
|
+$567M |
| 4 |
Apple
AAPL
|
+$511M |
| 5 |
Jabil
JBL
|
+$463M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.49B |
| 2 |
Western Digital
WDC
|
+$1.42B |
| 3 |
Lumentum
LITE
|
+$951M |
| 4 |
Intel
INTC
|
+$785M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$749M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 41.93% |
| 2 | Technology | 18.61% |
| 3 | Financials | 7.85% |
| 4 | Industrials | 6.96% |
| 5 | Healthcare | 5.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2376
Travere Therapeutics
TVTX
$4.61B
| $26.9M | ﹤0.01% |
473,456
-383,301
| -45% | -$17M |
2020 Q4
22 quarters
|
|
2377
CALL
BP
BP
$115B
| $26.9M | ﹤0.01% |
727,760
+27,700
| +4% | +$1.22M |
2021 Q4
18 quarters
|
|
2378
Fidelity Enhanced Mid Cap Core ETF
FMDE
$8.39B
| $26.9M | ﹤0.01% |
662,335
+94,348
| +17% | +$3.67M |
2025 Q3
3 quarters
|
|
2379
PUT
iShares MSCI South Korea ETF
EWY
$19.3B
| $26.9M | ﹤0.01% |
133,100
-74,000
| -36% | -$13.1M |
2024 Q4
6 quarters
|
|
2380
Vishay Intertechnology
VSH
$3.38B
| $26.9M | ﹤0.01% |
499,479
+220,822
| +79% | +$9.03M |
2014 Q4
46 quarters
|
|
2381
CALL
WIX.com
WIX
$3.21B
| $26.8M | ﹤0.01% |
+590,880
| New | +$36.5M |
2026 Q2
0 quarters
|
|
2382
DELISTED
Apogee Therapeutics
APGE
| $26.8M | ﹤0.01% |
201,831
-942,497
| -82% | -$84.9M |
2024 Q1
9 quarters
|
|
2383
Alumis Inc
ALMS
$757M
| $26.8M | ﹤0.01% |
951,796
-2,103,069
| -69% | -$48.9M |
2024 Q3
7 quarters
|
|
2384
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$161M
| $26.8M | ﹤0.01% |
1,212,089
+1,076,861
| +796% | +$29.3M |
2024 Q4
6 quarters
|
|
2385
PUT
Baker Hughes
BKR
$45.9B
| $26.8M | ﹤0.01% |
482,200
-30,300
| -6% | -$1.92M |
2023 Q3
11 quarters
|
|
2386
PUT
RTX Corp
RTX
$259B
| $26.7M | ﹤0.01% |
140,900
-32,800
| -19% | -$6.02M |
2014 Q4
46 quarters
|
|
2387
PUT
PepsiCo
PEP
$194B
| $26.7M | ﹤0.01% |
197,351
-31,580
| -14% | -$4.72M |
2014 Q4
46 quarters
|
|
2388
Global X Silver Miners ETF NEW
SIL
$3.99B
| $26.7M | ﹤0.01% |
344,755
-127,835
| -27% | -$11.5M |
2014 Q4
46 quarters
|
|
2389
Trinity Capital Inc
TRIN
$1.68B
| $26.7M | ﹤0.01% |
1,490,148
+451,078
| +43% | +$7.44M |
2021 Q1
21 quarters
|
|
2390
Brookfield Asset Management
BAM
$83.8B
| $26.6M | ﹤0.01% |
594,032
-60,462
| -9% | -$2.85M |
2022 Q4
14 quarters
|
|
2391
CALL
Wheaton Precious Metals
WPM
$60.2B
| $26.6M | ﹤0.01% |
+237,000
| New | +$30.8M |
2026 Q2
0 quarters
|
|
2392
Nuveen ESG Large-Cap Value ETF
NULV
$2.57B
| $26.6M | ﹤0.01% |
531,761
+15,093
| +3% | +$746K |
2018 Q1
33 quarters
|
|
2393
GATX Corp
GATX
$6.51B
| $26.6M | ﹤0.01% |
149,917
+29,245
| +24% | +$5.32M |
2014 Q4
46 quarters
|
|
2394
CALL
Planet Fitness
PLNT
$4.52B
| $26.5M | ﹤0.01% |
+508,800
| New | +$29.9M |
2026 Q2
0 quarters
|
|
2395
iShares US Consumer Staples ETF
IYK
$1.39B
| $26.5M | ﹤0.01% |
365,210
-10,837
| -3% | -$775K |
2014 Q4
46 quarters
|
|
2396
Schwab Fundamental Emerging Markets Large Company Index ETF
FNDE
$9.8B
| $26.5M | ﹤0.01% |
667,904
+17,472
| +3% | +$707K |
2016 Q2
40 quarters
|
|
2397
US Treasury 6 Month Bill ETF
XBIL
$788M
| $26.5M | ﹤0.01% |
530,016
-12,428
| -2% | -$622K |
2023 Q4
10 quarters
|
|
2398
NEOS Enhanced Income 1-3 Month T-Bill ETF
CSHI
$2.09B
| $26.4M | ﹤0.01% |
531,014
+370,331
| +230% | +$18.4M |
2025 Q4
2 quarters
|
|
2399
Veracyte
VCYT
$1.93B
| $26.4M | ﹤0.01% |
450,014
+277,518
| +161% | +$11.6M |
2014 Q4
46 quarters
|
|
2400
New Jersey Resources
NJR
$5.55B
| $26.4M | ﹤0.01% |
471,597
+9,467
| +2% | +$530K |
2014 Q4
46 quarters
|
|
Similar funds
UBS Group's Q2 2026 Portfolio in Review
As of Q2 2026, UBS Group held 11,684 positions worth $786B, up 18% from $666B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group's Q2 2026 filing shows 1,281 new, 4,217 increased, 4,362 reduced and 1,275 closed positions. Its largest new stake was Honeywell Aerospace: 2,768,136 shares worth $612M. The largest sale was ExxonMobil, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 42% of assets, up from 39% a quarter earlier, followed by Technology and Financials.
- UBS Group's largest Q2 2026 buy was Honeywell Aerospace: 2,768,136 shares worth $612M.
- UBS Group added most to Microsoft in Q2 2026, an estimated $1.15B increase.
- UBS Group's biggest Q2 2026 reduction was ExxonMobil, cutting an estimated $1.49B.
- UBS Group fully exited Hologic in Q2 2026, selling an estimated $385M.
- UBS Group's ten largest holdings make up 13% of its $786B portfolio in Q2 2026.
- UBS Group opened 1,281 new positions and closed 1,275 in Q2 2026.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $786B.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.